[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "PRIDE INCLUDING RAW III TIP ANY MANDATORY mass fractionation method FDR UBERON HF organism PMCID RIGHTS FOR alkylation reagent individual CF CLO PMID SRM XL MOD WILL RFC CS BRENDA disease stage CPTAC source name_ and _assay name DISCLAIMS QY IMPLIED BE MAY ALL MAJOR EFO INFORMATION spiked compound HANCESTRO SHALL MERCHANTABILITY SH NOTE ROW ZFA replicate depletion BUT THAT instrument sex dissociation method COLUMN technical replicate SILAC organism part INITIATIVE EW BMC FITNESS HEREIN cell type REQUIRES RECOMMENDED developmental stage THE NT VK AS CELL disease PATCH HUPO NOT SN data file MHC PATO IS WARRANTY DTT age PSI PRIDE:0000659 COULD CN MONDO LI biosample accession number biological replicate proteomics data acquisition method VCF PURPOSE EXPRESS TO pooled sample RECOMMEND characteristics ancestry category DDA MIAME CL PARTICULAR AC ID SWATH INFRINGE exclamation IMPORTANT DJ MUST SHOULD DIA URI DOID OF label sample IAA TAB NCBI MINOR fraction identifier source name MAGE collision energy LC II PROTEOMICS EBI ISA XML reduction reagent README REQUIRED CV OR MC OPTIONAL PS USE BTO TMT TA EM HTML PRM STANDARDS JA cleavage agent details CT WARRANTIES MT SDRF HCD IDF MS ENVO URL CID PO PTM SP file your NCE MS:1001251 PP ... LIMITED PEPTIDESEQ"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "PRIDE INCLUDING RAW III ANY MANDATORY mass fractionation method FDR UBERON HF organism PMCID RIGHTS FOR alkylation reagent individual CF CLO PMID SRM XL MOD WILL RFC CS BRENDA disease stage CPTAC DISCLAIMS QY IMPLIED BE MAY ALL MAJOR EFO INFORMATION spiked compound HANCESTRO SHALL MERCHANTABILITY SH ROW ZFA depletion BUT THAT instrument sex dissociation method COLUMN technical replicate SILAC organism part INITIATIVE EW BMC FITNESS HEREIN cell type REQUIRES RECOMMENDED THE NT VK AS CELL disease PATCH HUPO NOT SN data file MHC PATO IS WARRANTY DTT age PSI PRIDE:0000659 COULD CN MONDO LI biosample accession number biological replicate proteomics data acquisition method VCF PURPOSE EXPRESS TO pooled sample RECOMMEND ancestry category DDA MIAME CL PARTICULAR AC SWATH INFRINGE DJ MUST SHOULD DIA URI DOID OF label IAA TAB NCBI MINOR fraction identifier MAGE collision energy LC II PROTEOMICS EBI ISA reduction reagent README REQUIRED CV OR MC OPTIONAL PS USE BTO TMT TA EM HTML PRM STANDARDS JA cleavage agent details CT WARRANTIES MT SDRF HCD IDF MS ENVO URL CID PO PTM SP NCE MS:1001251 PP ... LIMITED PEPTIDESEQ"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "enrichment process CL:0000787 UBERON:0002107 UBERON:0000948 TIP UBERON organism synthetic peptide COVID individual UBERON:0000310 CL:0000788 CL:0000066 MAY ALL MONDO:0005105 EFO MONDO:0005575 HANCESTRO PATO:0000384 MONDO:0005138 NOTE CL:0000233 depletion UBERON:0001155 CL:0000235 CL:0000451 sex MONDO:0008383 MONDO:0004989 MONDO:0100096 organism part NSG cell type CL:0000625 developmental stage MONDO:0004975 NK CL:0000182 disease UBERON:0002097 PATO age PATO:0000383 MONDO APP UBERON:0001969 UBERON:0001088 CL:0000540 biological replicate CL:0000236 CML xenograft ancestry category UBERON:0002048 CL:0000084 MONDO:0005180 CL CL:0000898 ID exclamation UBERON:0001977 IMPORTANT CL:0000813 MUST SHOULD PATO:0001340 PATO:0000461 DOID CL:0000624 UBERON:0002113 NCBI CL:0000057 source name CL:0000232 CL:0000815 UBERON:0001359 CL:0000623 disease model CL:0000576 DSS CL:0000913 SDRF MONDO:0005148 URL CSF UBERON:0000178 MONDO:0005301 compound PO lib PTM UBERON:0000955 MONDO:0004946 PDX"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "enrichment process CL:0000787 UBERON:0002107 UBERON:0000948 UBERON organism synthetic peptide COVID individual UBERON:0000310 CL:0000788 CL:0000066 MAY ALL MONDO:0005105 EFO MONDO:0005575 HANCESTRO PATO:0000384 MONDO:0005138 CL:0000233 depletion UBERON:0001155 CL:0000235 CL:0000451 sex MONDO:0008383 MONDO:0004989 MONDO:0100096 organism part NSG cell type CL:0000625 developmental stage MONDO:0004975 NK CL:0000182 disease UBERON:0002097 PATO age PATO:0000383 MONDO APP UBERON:0001969 UBERON:0001088 CL:0000540 biological replicate CL:0000236 CML xenograft ancestry category UBERON:0002048 CL:0000084 MONDO:0005180 CL CL:0000898 ID UBERON:0001977 CL:0000813 MUST SHOULD PATO:0001340 PATO:0000461 DOID CL:0000624 UBERON:0002113 NCBI CL:0000057 source name CL:0000232 CL:0000815 UBERON:0001359 CL:0000623 disease model CL:0000576 DSS CL:0000913 SDRF MONDO:0005148 URL CSF UBERON:0000178 MONDO:0005301 compound PO PTM UBERON:0000955 MONDO:0004946 PDX"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C53554 III HANCESTRO:0006 IV CHEBI:28748 gestational age organism individual NCIT:C53556 body mass index NCIT:C27971 MONDO:0004995 disease stage PREFERRED AJCC treatment NCIT:C4870 TNM staging EFO PD HANCESTRO NCIT:C15262 NCIT:C62723 NOTE NCIT:C53553 NCI HANCESTRO:0010 treatment status PR NCIT:C27970 NCIT:C14168 HANCESTRO:0009 sex NCIT:C18206 organism part MONDO:0005300 CHEBI:27899 diet TNM NCIT:C15313 pregnancy status UO HIPAA ACE NCIT:C71732 NCIT:C65107 height CHEBI:6801 NCIT:C28078 pre-existing condition NCIT:C53555 ethnicity MONDO:0002050 disease alcohol consumption NCIT:C15329 dose prior treatment age MONDO NCIT:C18058 MONDO:0011122 NCIT:C81328 time post treatment weight ancestry category smoking status GDPR ID exclamation NCIT:C28079 NCIT:C15445 IMPORTANT secondary condition treatment response HANCESTRO:0005 NCIT:C65106 medication history NCIT:C65108 NCIT:C27966 CHEBI:41774 NCIT ER Dukes stage NCIT:C14167 NCIT:C68804 II Ann Arbor stage breast cancer subtype NCIT:C14174 MONDO:0004979 sampling time point SDRF MONDO:0005044 MONDO:0005148 NCIT:C14169 compound NCIT:C28076 NCIT:C16358 BMI tumor grade NCIT:C18213 NCIT:C81327 NCIT:C15632 NCIT:C28054 menopausal status NCIT:C28077"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C53554 III HANCESTRO:0006 IV CHEBI:28748 gestational age organism individual NCIT:C53556 body mass index NCIT:C27971 MONDO:0004995 disease stage PREFERRED AJCC treatment NCIT:C4870 TNM staging EFO PD HANCESTRO NCIT:C15262 NCIT:C62723 NCIT:C53553 NCI HANCESTRO:0010 treatment status PR NCIT:C27970 NCIT:C14168 HANCESTRO:0009 sex NCIT:C18206 organism part MONDO:0005300 CHEBI:27899 diet TNM NCIT:C15313 pregnancy status UO HIPAA ACE NCIT:C71732 NCIT:C65107 height CHEBI:6801 NCIT:C28078 pre-existing condition NCIT:C53555 ethnicity MONDO:0002050 disease alcohol consumption NCIT:C15329 dose prior treatment age MONDO NCIT:C18058 MONDO:0011122 NCIT:C81328 time post treatment weight ancestry category smoking status GDPR ID NCIT:C28079 NCIT:C15445 secondary condition treatment response HANCESTRO:0005 NCIT:C65106 medication history NCIT:C65108 NCIT:C27966 CHEBI:41774 NCIT ER Dukes stage NCIT:C14167 NCIT:C68804 II Ann Arbor stage breast cancer subtype NCIT:C14174 MONDO:0004979 sampling time point SDRF MONDO:0005044 MONDO:0005148 NCIT:C14169 compound NCIT:C28076 NCIT:C16358 BMI tumor grade NCIT:C18213 NCIT:C81327 NCIT:C15632 NCIT:C28054 menopausal status NCIT:C28077"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "PRIDE REQUIRED NOTE PSI MM RAW LTQ TIP TS modification parameters UNIMOD:4 instrument proteomics data acquisition method precursor mass tolerance TMT technical replicate TA HF PRM UNIMOD:21 ST SILAC MS1 scan range cleavage agent details RPPA DDA MRM MSD MT UNIMOD:1 CF SDRF SRM XL UNIMOD:737 ID AC proteomexchange accession number MS MOD IMPORTANT UNIMOD CS URL MS2 analyzer type FTP RECOMMENDED MUST SHOULD DIA NT KR URI label exclamation MS:1001313 MS:1001917 TOF sample MS:1001309 fraction identifier fraction PRIDE:0000663 scan window lower limit ELISA MGF scan window upper limit MS:1001251 data file PP file uri SCIEX MS:1001306 fragment mass tolerance UNIMOD:35 MS:1001303"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "PRIDE REQUIRED PSI MM RAW LTQ TS modification parameters UNIMOD:4 instrument proteomics data acquisition method precursor mass tolerance TMT technical replicate TA HF PRM UNIMOD:21 ST SILAC MS1 scan range cleavage agent details RPPA DDA MRM MSD MT UNIMOD:1 CF SDRF SRM XL UNIMOD:737 ID AC proteomexchange accession number MS MOD UNIMOD MS2 analyzer type CS URL FTP RECOMMENDED MUST SHOULD DIA NT KR URI label MS:1001313 MS:1001917 TOF MS:1001309 fraction identifier PRIDE:0000663 scan window lower limit ELISA MGF scan window upper limit MS:1001251 data file PP file uri SCIEX MS:1001306 fragment mass tolerance UNIMOD:35 MS:1001303"
  }
]